Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas

Varun, Chopra; Dineshkumar, Thayalan; Jayant, VS; Rameshkumar, Annasamy; Rajkumar, Krishnan; Rajashree, Padmanaban; Mathew, Jacob; Arunvignesh, Rajendran K

추천

검색

자료유형: 학술저널

저자정보: Varun, Chopra (Oral and Maxillofacial Pathology, Indian Ocean Dental School and Hospital) Dineshkumar, Thayalan (Oral and Maxillofacial Pathology, SRM Dental College) Jayant, VS (Oral and Maxillofacial Pathology, SRM Dental College) Rameshkumar, Annasamy (Oral and Maxillofacial Pathology, SRM Dental College) Rajkumar, Krishnan (Oral and Maxillofacial Pathology, SRM Dental College) Rajashree, Padmanaban (Research Faculty, SRM Dental College) Mathew, Jacob (Department of Oral and Maxillofacial Pathology, Vinayaka Mission's Sankarachariyar Dental College) Arunvignesh, Rajendran K (Oral and Maxillofacial Pathology, SRM Dental College)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제14호

발행연도: 2015.1

수록면: 5,773 - 5,777 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Oral squamous cell carcinoma (OSCC) is thought to develop from precancerous dysplastic lesions through multistep processes of carcinogenesis involving activation of oncogenes and loss of tumor suppressor genes. The human epidermal growth factor receptor 2 (Her-2/neu [erbB-2]), a cell membrane glycoprotein, is a growth factor receptor that has receptor tyrosine kinase activity. Her2/neu activation plays a central role in cell proliferation and survival. It has been shown that overexpression of Her2/neu increases the rate of cell division and growth, leading to precancerous changes. The aim of the present study was to compare the serum and salivary Her2/neu levels between cases with premalignant and malignant oral lesions. Materials and Methods: Fasting blood samples and unstimulated saliva by passive drooling were collected from three groups of healthy control (n=20), premalignant disorder (PMD) (n=20) and OSCC (n=25) subjects. The HER2 extracellular domain (HER2 ECD) levels were measured using ELISA. Results: The levels of serum Her2/neu showed no significant differences between any of the groups but on the other hand salivary Her2/neu levels were found to be significantly (p<0.05) higher when compared between control (median 68.7 pg/ml, range: 21.5 - 75.8) and OSCC (median 145.6 pg/ml, range: 45.1-191.1). A similar trend was observed when comparing between PMD (median 43.3, range: 22.1 -94.7) and OSCC with a statistical significance of p<0.05. Conclusions: Our study provided evidence of increased salivary Her2/neu in OSCC when compared to PMD and control which was not the case for serum levels. This suggests that probably Her2/neu is not highly amplified as in breast cancer so as to be reflected in serum. Since saliva is in local vicinity of the OSCC, even a mild increase might be mirrored. On the whole, this study proposes Her2/neu as marker for distinguishing premalignant and malignant conditions.

#Her2/neu ECD level #oral SCC #premalignant disorder #differentiaion

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!